LLY

931.66

+2.23%↑

UNH

597.99

+0.06%↑

NVO

119.89

+2.03%↑

JNJ

161.35

+0.45%↑

ABBV

194.33

-0.02%↓

LLY

931.66

+2.23%↑

UNH

597.99

+0.06%↑

NVO

119.89

+2.03%↑

JNJ

161.35

+0.45%↑

ABBV

194.33

-0.02%↓

LLY

931.66

+2.23%↑

UNH

597.99

+0.06%↑

NVO

119.89

+2.03%↑

JNJ

161.35

+0.45%↑

ABBV

194.33

-0.02%↓

LLY

931.66

+2.23%↑

UNH

597.99

+0.06%↑

NVO

119.89

+2.03%↑

JNJ

161.35

+0.45%↑

ABBV

194.33

-0.02%↓

LLY

931.66

+2.23%↑

UNH

597.99

+0.06%↑

NVO

119.89

+2.03%↑

JNJ

161.35

+0.45%↑

ABBV

194.33

-0.02%↓

Search

Catalent Inc

Cerrado

Sector Salud

60.44 -0.31

Resumen

Variación precio

24h

Actual

Mínimo

60.41

Máximo

60.76

Métricas clave

By Trading Economics

Ingresos

124M

23M

Ventas

180M

1.3B

P/B

Media del Sector

28.82

113.916

BPA

0.65

Margen de beneficio

1.769

EBITDA

83M

105M

Recomendaciones

By TipRanks

Recomendaciones

Neutral

Estimación a 12 meses

+5.05 upside

Dividendos

By Dow Jones

Próximas Ganancias

13 nov 2024

Estadísticas de Mercado

By TradingEconomics

Capitalización de Mercado

28M

11B

Apertura anterior

60.75

Cierre anterior

60.44

Noticias sobre sentimiento de mercado

By Acuity

50%

50%

193 / 366 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Bullish Evidence

Catalent Inc Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

3 may 2024, 13:51 UTC

Adquisiciones, fusiones, absorciones

FTC Seeks More Info On $16.5 Billion Novo/Catalent Deal

5 feb 2024, 14:50 UTC

Adquisiciones, fusiones, absorciones

Novo Holdings to Buy Catalent for $11.5 Billion in Cash -- 4th Update

5 feb 2024, 13:11 UTC

Adquisiciones, fusiones, absorciones

Novo Holdings to Buy Catalent for $11.5 Billion in Cash -- 3rd Update

5 feb 2024, 12:09 UTC

Adquisiciones, fusiones, absorciones

Novo Holdings to Buy Catalent in $16.5 Billion Deal -- 2nd Update

5 feb 2024, 11:38 UTC

Adquisiciones, fusiones, absorciones

Novo Nordisk Buys Manufacturing Sites as Part of Novo Holdings' Acquisition of Catalent

5 feb 2024, 11:31 UTC

Adquisiciones, fusiones, absorciones

Novo Holdings Buying Catalent in $16.5 Billion Deal -- Update

5 feb 2024, 11:23 UTC

Adquisiciones, fusiones, absorciones

Novo Holdings Buying Catalent in $16.5 Billion Deal

23 mar 2024, 13:00 UTC

Principales Noticias

U.S.-China Decoupling Poses Supply-Chain Risks for Drug Companies -- Heard on the Street -- WSJ

5 feb 2024, 18:04 UTC

Adquisiciones, fusiones, absorciones

Wegovy Maker to Boost Production Capacity With Multibillion-Dollar Deal -- WSJ

5 feb 2024, 17:27 UTC

Ganancias
Adquisiciones, fusiones, absorciones

Novo Nordisk Makes the Latest Big Pharma Deal. Why More Are Coming. -- Barrons.com

5 feb 2024, 15:36 UTC

Adquisiciones, fusiones, absorciones

Novo Nordisk To Up Production Capacity As Parent Buys Catalent -- IBD

5 feb 2024, 11:38 UTC

Adquisiciones, fusiones, absorciones

Catalent Stock Jumps on $16.5 Billion Sale to Controlling Shareholder of Ozempic Maker Novo Nordisk -- Barrons.com

5 feb 2024, 11:15 UTC

Adquisiciones, fusiones, absorciones

Novo Nordisk's Controlling Shareholder To Buy Catalent For $16.5 Billion -- MarketWatch

5 feb 2024, 11:08 UTC

Adquisiciones, fusiones, absorciones

Novo Nordisk: Manufacturing Sites Are in Italy, Belgium and US

5 feb 2024, 11:08 UTC

Adquisiciones, fusiones, absorciones

Novo Nordisk Buys Sites From Novo Holdings as Part of Novo Holdings' Deal to Buy Catalent

5 feb 2024, 11:06 UTC

Adquisiciones, fusiones, absorciones

Novo Nordisk Agrees to Buy Three Manufacturing Sites For Upfront Payment of $11 Bln

5 feb 2024, 11:03 UTC

Adquisiciones, fusiones, absorciones

Catalent: Merger Is Expected to Close Towards the End of Calendar Yr 2024 >CTLT

5 feb 2024, 11:02 UTC

Adquisiciones, fusiones, absorciones

Catalent: Of Co's More Than 50 Global Sites, Novo Holdings Intends to Sell Three Catalent Fill-Finish Sites and Related Assets Acquired in Merger to Novo Nordisk >CTLT

Comparación entre iguales

Cambio de precio

Catalent Inc Esperado

Precio Objetivo

By TipRanks

5.05% repunte

Estimación a 12 meses

Media 63.5 USD  5.05%

Máximo 63.5 USD

Mínimo 63.5 USD

De acuerdo con 1 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Catalent Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Neutral

1 ratings

0

Comprar

1

Mantener

0

Vender

Puntuación técnica

By Trading Central

60.08 / 60.52Soporte y Resistencia

Corto Plazo

Bullish Evidence

Medio plazo

Bearish Evidence

Largo Plazo

Weak Bearish Evidence

Sentimiento

By Acuity

193 / 366 Clasificación en Salud

Noticias sobre sentimiento de mercado

Neutral

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Catalent Inc

Catalent, Inc. provides delivery technologies, and development and manufacturing solutions for drugs; protein, cell, and gene therapy biologics; and consumer health products. Its segments include Softgel and Oral Technologies, Biologics, Oral and Specialty Delivery, and Clinical Supply Services. The Softgel and Oral Technologies segment is engaged in providing formulation, development, and manufacturing services for soft capsules, as well as largescale manufacturing of oral solid dose forms. The Biologics segment provides biologic cell-line, cell therapy and viral vector gene therapy development and manufacturing services. The Oral and Specialty Delivery segment provides formulation development and manufacturing across a range of technologies along with integrated downstream clinical development and commercial supply solutions. The Clinical Supply Services segment is engaged in manufacturing, packaging, distribution and inventory management for drugs and biologics in clinical trials.